2211 — Universal Health International Holding Income Statement
0.000.00%
Last trade - 00:00- HK$79.59m
- HK$35.05m
- CNY711.51m
Annual income statement for Universal Health International Holding, fiscal year end - June 30th, CNY millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Preliminary |
| Revenue | |||||
| Total Revenue | 1,274 | 1,297 | 1,089 | 712 | 519 |
| Cost of Revenue | |||||
| Gross Profit | 204 | 214 | 180 | 113 | 87.8 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,462 | 1,395 | 1,089 | 737 | 531 |
| Operating Profit | -189 | -98.4 | 0.082 | -25.5 | -11.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -188 | -112 | -2.79 | -22.9 | -17 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -188 | -106 | 0.58 | -25.7 | -20.4 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -188 | -105 | 0.413 | -26 | -20.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -188 | -105 | 0.413 | -26 | -20.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.89 | -1.27 | -0.172 | -0.227 | -0.124 |